Daiwa Securities Group »

Halozyme Therapeutics shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 2.5M 0.86
2023-09-30 $3.3M 3.9M 0.85
2022-03-31 $2.2M 2.5M 0.88

More positions owned by Daiwa Securities Group

Prologis (PLD)
Welltower Inc Com reit (WELL)
Simon Property (SPG)
Digital Realty Trust (DLR)
Invitation Homes (INVH)
Realty Income (O)
Equinix (EQIX)
Global X Fds Conscious Cos (KRMA)
Extra Space Storage (EXR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Sun Communities (SUI)
Iron Mountain (IRM)
Vici Pptys (VICI)
Kimco Realty Corporation (KIM)

View all positions for Daiwa Securities Group

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics